Skip to main content
TipRanks
Go Ultimate75% OFF

Corbus Pharmaceuticals (CRBP) Drug Pipeline

2,652 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Cetuximab, Docetaxel, Crb-701, CapcitabineOropharyngeal Carcinoma (Opc)Phase IIINot Yet RecruitingA Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell CarcinomaAug 12, 2026―
Crb-913Obese But Otherwise Healthy ParticipantsPhase IActive Not RecruitingA 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With ObesityDec 16, 2025
Crb-601 Monoclonal Antibody, Anti-Pd-1 Monoclonal AntibodySolid Tumorphase1AndPhase2RecruitingFirst-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.Sep 13, 2024
Crb-701, Anti-Pd-1Solid Tumor, Adultphase1AndPhase2RecruitingA Phase 1/2 Study to Investigate CRB-701 in Solid TumorsFeb 08, 2024

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Corbus Pharmaceuticals Holdings (CRBP) have in its pipeline
Corbus Pharmaceuticals CRBP is currently developing the following drugs: Cetuximab, Docetaxel, Crb-701, Capcitabine, Crb-913, Crb-601 Monoclonal Antibody, Anti-Pd-1 Monoclonal Antibody, Crb-701, Anti-Pd-1. These drug candidates are in various stages of clinical development as the company works toward FDA approval.